Saregama India Intrinsic Value
Saregama India (SAREGAMA) median intrinsic value is ₹625.26 from 9 valuation models (range ₹149–₹1241), vs current price ₹496.50 — +25.9% upside (Trading Below Calculated Value), margin of safety 20.6%. Read SAREGAMA ex-dividend dates for the complete payout history and dividend yield track record.
SAREGAMA Valuation Methods Summary — DCF, Graham Number & P/E
Saregama India intrinsic value across 9 models vs current price ₹496.50 — upside/downside and value range per method. Analyse Saregama India ownership structure to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹231.60 | ₹185.28 - ₹277.92 | -53.4% | EPS: ₹15.44, Sector P/E: 15x |
| Book Value Method | asset | ₹891.05 | ₹801.94 - ₹980.15 | +79.5% | Book Value/Share: ₹891.05, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹625.26 | ₹562.73 - ₹687.79 | +25.9% | Revenue/Share: ₹625.26, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹993.00 | ₹893.70 - ₹1092.30 | +100.0% | EBITDA: ₹516.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1241.25 | ₹993.00 - ₹1489.50 | +150.0% | CF Growth: 14.9%, Discount: 15% |
| PEG Ratio Method | growth | ₹148.95 | ₹134.06 - ₹163.84 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹159.03 | ₹143.13 - ₹174.93 | -68.0% | Revenue Growth: 6.0%, Adj P/E: 10.3x |
| ROE Based Valuation | profitability | ₹993.00 | ₹893.70 - ₹1092.30 | +100.0% | ROE: 17.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹556.37 | ₹500.73 - ₹612.01 | +12.1% | EPS: ₹15.44, BVPS: ₹891.05 |
SAREGAMA Intrinsic Value vs Market Price — All Valuation Models
Saregama India fair value range ₹149–₹1241 vs current market price ₹496.50 across 9 valuation models. For current market price and key ratios, visit Saregama India stock price NSE.
SAREGAMA Intrinsic Value Analysis — Undervalued or Overvalued?
Saregama India median intrinsic value ₹625.26, current price ₹496.50 — Trading Below Calculated Value by 25.9%, margin of safety 20.6%.
What is the intrinsic value of SAREGAMA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Saregama India (SAREGAMA) is ₹625.26 (median value). With the current market price of ₹496.50, this represents a +25.9% variance from our estimated fair value.
The valuation range spans from ₹148.95 to ₹1241.25, indicating ₹148.95 - ₹1241.25.
Is SAREGAMA undervalued or overvalued?
Based on our multi-method analysis, Saregama India (SAREGAMA) appears to be trading below calculated value by approximately 25.9%.
SAREGAMA Financial Health — Key Ratios vs Industry Benchmarks
Saregama India financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 42.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.51x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SAREGAMA Cash Flow Quality — Operating & Free Cash Flow
Saregama India operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹331 Cr | ₹221 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹93 Cr | ₹93 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹93 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹94 Cr | ₹-221 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹190 Cr | ₹122 Cr | Positive Free Cash Flow | 8/10 |